Update on IV Solution Supply Chain Issues Due to Hurricane Helene
(Oct. 29, 2024) Baxter issued an announcement on Oct. 28th providing an update on the supply chain issues resulting from Hurricane Helene. It is notable that the Food and Drug Administration (FDA) has authorized the extension of certain intravenous (IV) solution products produced before the end of September 2024; see Baxter’s full list of product codes for more information. The update also provides information regarding various steps being taken to get the North Carolina plant back online and draw upon a global network to meet the supply needs.
Members should alert us to any serious access issues. Baxter has also provided the following email for customers who need additional assistance beyond their existing communications channels with Baxter: HurricaneHeleneSupport@baxter.com.
Contact: Diane Darbyshire, ddarbyshire@leadingageny.org, 518-867-8828